Heron Therapeutics
HRTX
#8265
Rank
C$0.22 B
Marketcap
$1.48
Share price
-5.36%
Change (1 day)
-17.50%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.58

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.63. In 2022 the company made an earnings per share (EPS) of -$2.42 an increase over its 2021 EPS that were of -$3.14.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.58-34.66%
2022-$2.42-23.11%
2021-$3.14-10%
2020-$3.49-0%
2019-$3.491.21%
2018-$3.45-32.7%
2017-$5.13-19.34%
2016-$6.3654.76%
2015-$4.111.73%
2014-$4.04-16.23%
2013-$4.8291.67%
2012-$2.51-31.45%
2011-$3.67-27.06%
2010-$5.03-43.75%
2009-$8.94-57.33%
2008-$20.95-82.92%
2007-$122.6620.61%
2006-$101.70175.76%
2005-$36.88-21.43%
2004-$46.94100%
2003-$23.47-38.24%
2002-$38.00161.54%
2001-$14.53-106.46%
2000$224.772051.55%
1999$10.45839.73%
1998$1.11-105.48%
1997-$20.30-88.16%
1996-$171.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.82-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.20-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.28 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.19-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.31 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA